In recent years, CoolSculpting has become one of the most popular nonsurgical alternatives to liposuction. This procedure utilizes cryolipolysis technology to freeze fat cells, causing them to wither and die. Your body will then safely remove these dead fat cells, leaving you with a more toned, sculpted figure. Dr. Fitzgerald can use CoolSculpting to remove targeted pockets of fat in many areas of your body, including your:
The “AXA PPP Group” for this purpose is AXA PPP healthcare Group Limited, its holding company and all subsidiaries of its holding company including (but not limited to) AXA PPP healthcare Limited, AXA ICAS Limited, AXA ICAS Occupational Health Services Limited, Health on Line Company UK Limited and AXA PPP healthcare Administration Services Limited.
As a Harvard and NYU-educated, board-certified plastic surgeon, Dr. Rapaport has a track record of over 24 years of achieving exquisite results for his clients, and is dedicated to providing the most innovative and groundbreaking new treatments on the market. He is joined by Dr. Darren Smith, another experienced surgeon in body contouring and other minimally/non-invasive treatments. At Coolspa, each patient receives a customized, one-on-one consultation and treatment that targets their unique trouble zones. This personalized attention coupled with expert skill and artistry is the reason why Coolspa is known as NYC’s premier body sculpting center.
The ACCUSCULPT™ procedure is an exciting body contouring treatment developed to meet the needs of patients seeking significant results with minimal downtime. It is ideal for areas such as the hips, thighs, knees, bra line, arms, and chest. Your physician uses the AccuSculpt contouring system to remove excess fat deposits that have settled in the target regions, which also results in overall skin tightening of the treated areas. Patented technology makes the procedure safer, more effective and less invasive than competing technologies.
1 July 2015: The CMA is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.